2022
DOI: 10.1177/23259582211069767
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of Prenatal HIV Screening in Massachusetts: Examining Patterns in Prenatal HIV Screening Using the Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2016

Abstract: Prenatal HIV screening is critical to eliminate mother-to-child (MTC) HIV transmission. Although Massachusetts (MA) has near-zero MTC transmission rates, recent trends in statewide prenatal HIV testing are unknown. This study examined variations in prenatal HIV screening across race/ethnicity, socioeconomic status, and prenatal care settings in MA, in the period following national and state-level changes in guidance encouraging routine prenatal HIV testing. According to the MA Pregnancy Risk Assessment Monito… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Repeat screening has not been well-studied in lower incidence settings, but only 82.4% of pregnant individuals nationally receive any prenatal screen for HIV infection, 43 and as low as 68.3% of patients are screened on a state-by-state basis. 44…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Repeat screening has not been well-studied in lower incidence settings, but only 82.4% of pregnant individuals nationally receive any prenatal screen for HIV infection, 43 and as low as 68.3% of patients are screened on a state-by-state basis. 44…”
Section: Discussionmentioning
confidence: 99%
“…Repeat screening has not been well- studied in lower incidence settings, but only 82.4% of pregnant individuals nationally receive any prenatal screen for HIV infection, 43 and as low as 68.3% of patients are screened on a state-by-state basis. 44 Accurately modeling HIV screening pathways to reflect the reality of clinical implementation is challenging. This is partially due to imperfect adherence to guidelines as well as barriers to care among individuals at greatest risk for infection.…”
Section: Discussionmentioning
confidence: 99%